• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Medical Device Problem Codes Failure to Advance (2524); Material Integrity Problem (2978)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/19/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported coating peeled off.During a superficial femoral artery (sfa) occlusion case, a 5.0 x 100mm, 135cm ranger drug-coated balloon (dcb) was selected for use.Multiple attempts were made to cross the lesion with the ranger, but it was unsuccessful even after the lesion was dilated.The device was inserted inside the patient twice, and there was a concern that the drug coating might have peeled off.Another 5mm x 150mm ranger dcb was opened, and the procedure was completed after crossing the lesion.There were no patient complications.
 
Additional Manufacturer Narrative
Device evaluated by mfr: returned product consisted of a ranger drug coated balloon catheter.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined and revealed no damage.The loading tool is still coving the balloon and the drug coating is still visible.There was no evidence of any damage or irregularities contributing to the reported crossing difficulty, which could not be confirmed because the clinical circumstances could not be replicated.Product analysis confirmed the drug coating is still visible.
 
Event or Problem Description
It was reported coating peeled off.During a superficial femoral artery (sfa) occlusion case, a 5.0 x 100mm, 135cm ranger drug-coated balloon (dcb) was selected for use.Multiple attempts were made to cross the lesion with the ranger, but it was unsuccessful even after the lesion was dilated.The device was inserted inside the patient twice, and there was a concern that the drug coating might have peeled off.Another 5mm x 150mm ranger dcb was opened, and the procedure was completed after crossing the lesion.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
500 commander shea boulevard
quincy MA 02171
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13522296
Report Number2134265-2022-01498
Device Sequence Number4385419
Product Code ONU
UDI-Device Identifier08714729975984
UDI-Public08714729975984
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P190019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/29/2022
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number0027455807
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/20/2022
Supplement Date Received by Manufacturer03/04/2022
Initial Report FDA Received Date02/14/2022
Supplement Report FDA Received Date03/23/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/29/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GUIDEWIRE: JUPITER; GUIDEWIRE: JUPITER; INTRODUCER SHEATH: PARENT; INTRODUCER SHEATH: PARENT
Patient SexUnknown
-
-